Trending Online CME/CE

Challenges and Opportunities in Hodgkin Lymphoma

NEW ACTIVITY | 1.0 CME | 1.0 CE
In this online activity, Craig H. Moskowitz, MD and Kami Maddocks, MD discuss factors that increase risk for cHL treatment failure, emerging data on the treatment of newly diagnosed and relapsed/refractory cHL, and assess strategies to manage toxicities associated with therapy.

Current Challenges and New Opportunities in Follicular Lymphoma

NEW ACTIVITY | 1.25 CME | 1.2 CE
Watch this case-based CME/CE-certified recording with Christopher R. Flowers, MD, MS as he discusses emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL.

Current Trends in the Management of Castration-Resistant Prostate Cancer

NEW ACTIVITY | 1.0 CME | 1.0 CE
In this case-based activity, Alicia K. Morgans, MD, MPH and Tanya Dorff, MD discuss predictive and prognostic markers, recent findings, novel treatments, and supportive care plans for patients with castration-resistant prostate cancer.

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

NEW ACTIVITY | 1.0 CME | ILNA Points
Watch this CME-certified discussion with Brian I. Rini, MD, FACP from Cleveland Clinic Lerner College of Medicine as he discusses emerging data on targeted therapies for the treatment of patients with advanced RCC.

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

NEW ACTIVITY | 1.0 CME/CE | ILNA Points
This case-based online activity features a discussion between leading clinical investigators, Ramez Eskander, MD and Bradley Monk, MD, FACS, FACOG, as they explore the management of advanced cervical cancer with checkpoint inhibitor therapy.

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

NEW ACTIVITY | 1.0 CE | ILNA Points
In this CE-certified online activity, Constance Visovsky, PhD, RN, ACNP, FAAN discusses treatment planning, CDK4/6 inhibitor safety profiles, and supportive care strategies for patients with metastatic breast cancer.

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

0.8 CE | ILNA Points

In this case-based activity, Pamela Ryan, RN, BSN from Ochsner Medical Center and Donna Williams, RN from Stanford Medicine discuss signs and symptoms of carcinoid syndrome in patients with NETs and the application of supportive care strategies to provide symptom relief.

Nursing Management of Oral Mucositis

1.0 CE | ILNA Points
Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions.

Nursing Management of Bone Health in Patients With Cancer

1.0 CE | ILNA Points
Once it has metastasized to the skeletal system, cancer often negatively affects bone health, leading to pain, fractures, hypercalcemia, and nerve compression. This online activity reviews interventions to reduce morbidity and mortality of bone complications in patients with cancer

Nursing Management of Cancer Treatment-Induced Cardiotoxicity

1.0 CE | ILNA Points
Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of treatment-induced cardiotoxicity.

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

1.0 CE | ILNA Points
CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.

Prevention of Medical Errors in Nursing Practice

1.0 CE | ILNA Points
Medical errors are among the most common health-threatening mistakes that affect patient care. This online activity reviews the categories of medication errors, at-risk patient populations, and best practices in error analysis and reporting.

Nursing Management of Tumor Lysis Syndrome

1.0 CE | ILNA Points
TLS is an oncological emergency which can result in acute renal failure, cardiac arrhythmias, seizures, and even death. This online activity reviews signs and symptoms, risk factors, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer

1.0 CE | ILNA Points
VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer

1.0 CE | ILNA Points

VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews venous thromboembolism pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients.

Management of Cancer Pain: Current Guidelines

1.0 CE | ILNA Points
Pain is among the most debilitating symptoms cancer patients experience. This online activity reviews the pathophysiology of cancer pain and scientific principles of pain management, assessment, and emerging concepts in pharmacological management.

088

CME/CE Live Meetings

Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer

1.5 CNE | Satellite Symposium
Are you attending ONS Congress 2019? Don't miss our complimentary dinner satellite symposium on optimizing treatment experiences for patients with castration-resistant prostate cancer. Register today!

Challenges and Opportunities in Castration-Resistant Prostate Cancer

1.0 CME/CE/CPE | VA/DoD Meeting Series

This live activity will bring a leading clinical investigator to your VA/DoD medical center to discuss emerging data on treatment selection, resistance, and response in CRPC. Schedule a meeting at your institution today!

Evolving Treatment Paradigms in Multiple Myeloma and Implications for Shared Decision Making

1.0 CME/CE/CPE | Visiting Faculty Meeting Series
This activity will bring a leading clinical investigator to your cancer center to discuss personalized care plans, novel therapies, and supportive care strategies for patients with MM. Schedule a meeting at your institution today!

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

1.0 CME | Visiting Faculty Meeting Series

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!

Current Challenges and New Opportunities in Follicular Lymphoma

1.0 CME/CE | Visiting Faculty Meeting Series

This live activity will bring a leading clinical investigator to your cancer center to discuss emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL. Enroll your institution today!

Company

Resources

Follow Us

© Copyright 2019 i3 Health. All rights reserved.